In addition to Th1, Th2, and Th17 lineage, regulatory T cells (Tregs), a special subset of CD4+ T cells, inhibit atherosclerosis development by attenuating activated T cell responses [6, 7]. The gene discussed is CD4; the disease is atherosclerosis.